The impact of cost-effectiveness of country specific application-the case of drotrecogin alfa (activated) in severe sepsis

被引：0
|
作者：
Persson, U
Hjelmgren, J
Ragnarson, TG
Davies, A
机构：
[1] IHE, Lund, Sweden
[2] Medtap Int, London, England
来源：
VALUE IN HEALTH | 2003年 / 6卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)61917-1
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：752 / 753
页数：2
相关论文
共 50 条
  • [31] The development of drotrecogin alfa (activated) for the treatment of severe sepsis
    Macias, WL
    Yan, SB
    Grinnell, BW
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2004, 27 (05): : 360 - 370
  • [32] Clinical trials in severe sepsis with drotrecogin alfa (activated)
    Pierre-François Laterre
    Critical Care, 11
  • [33] Readministration of drotrecogin alfa (activated) in an adult with severe sepsis
    Scipione, Marco R.
    Nogid, Boris
    Davanos, Evangelia
    DiGregorio, Robert V.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (18) : 1711 - 1715
  • [34] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Choi, Goda
    de Pont, Anne-Cornelie J. M.
    Schultz, Marcus J.
    CRITICAL CARE, 2006, 10 (04):
  • [35] Clinical trials in severe sepsis with drotrecogin alfa (activated)
    Laterre, Pierre-Francois
    CRITICAL CARE, 2007, 11 (Suppl 5):
  • [36] Timing of drotrecogin alfa (activated) treatment in severe sepsis
    Goda Choi
    Anne-Cornélie JM de Pont
    Marcus J Schultz
    Critical Care, 10
  • [37] Hemorrhagic risk of (activated) drotrecogin alfa in severe sepsis
    Perrotin, D
    ANNALES FRANCAISES D ANESTHESIE ET DE REANIMATION, 2003, 22 : 16 - 19
  • [38] Comparing the cost-effectiveness of drotrecogin alfa (activated) across three European countries
    Neilson, AR
    Schneider, H
    Finnern, HW
    INTENSIVE CARE MEDICINE, 2003, 29 : S93 - S93
  • [39] Effectiveness and safety of drotrecogin alfa (activated) for severe sepsis: a meta-analysis and metaregression
    Kalil, Andre C.
    LaRosa, Steven P.
    LANCET INFECTIOUS DISEASES, 2012, 12 (09): : 678 - 686
  • [40] Drotrecogin alfa (activated) treatment of older patients with severe sepsis
    Ely, EW
    Angus, DC
    Williams, MD
    Bates, B
    Qualy, R
    Bernard, GR
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (02) : 187 - 195
12345